The Role of D-Dimers in the Initial Evaluation of COVID-19 [Response To Letter].

IF 2.3 3区医学 Q2 HEALTH CARE SCIENCES & SERVICES

Therapeutics and Clinical Risk Management Pub Date : 2022-01-01 DOI:10.2147/TCRM.S373236

Liliana Baroiu, Ana Cristina Lese, Ioana Anca Stefanopol, Alina Iancu, Caterina Dumitru, Alexandru Bogdan Ciubara, Florin Ciprian Bujoreanu, Nicusor Baroiu, Anamaria Ciubara, Alexandru Nechifor, Lucretia Anghel, Alin Laurentiu Tatu

引用次数: 0

查看原文本刊更多论文

d -二聚体在COVID-19初步评估中的作用[回信]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Therapeutics and Clinical Risk Management HEALTH CARE SCIENCES & SERVICES-

CiteScore

4.80

自引率

3.60%

发文量

139

审稿时长

16 weeks

期刊介绍： Therapeutics and Clinical Risk Management is an international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas. The journal welcomes submissions covering original research, clinical and epidemiological studies, reviews, guidelines, expert opinion and commentary. The journal will consider case reports but only if they make a valuable and original contribution to the literature. As of 18th March 2019, Therapeutics and Clinical Risk Management will no longer consider meta-analyses for publication. The journal does not accept study protocols, animal-based or cell line-based studies.